ESC 365 - Clinical characteristics of apixaban prescription in AF patients with single dose-reduction criterion: ASPIRE (efficacy and safety of apixaban in real-world practice in Korean frail patients with AF)

ESC Professional Premium Access

Clinical characteristics of apixaban prescription in AF patients with single dose-reduction criterion: ASPIRE (efficacy and safety of apixaban in real-world practice in Korean frail patients with AF)

Session: Prognosis and outcome in patients with atrial fibrillation

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor J. Choi (Seoul, KR)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Jungmin Choi

Seoul National University Hospital, Seoul (Korea (Republic of))

0 follower

7 more presentations in this session

Cigarette smoking and structural brain deficits in patients with atrial fibrillation

Speaker: Mr R. Peter (Basel, CH)

The current and future total health care costs of atrial fibrillation

Speaker: Doctor R. Sandhu (Los Angeles, US)

Association of atrial fibrillation burden with rhythm control and stroke prevention interventions among patients with cardiac implantable electronic devices

Speaker: Doctor G. Peigh (Chicago, US)

Risk differences between atrial fibrillation patients with different clinical phenotypes: insights from the French population

Speaker: Doctor A. Fawzy (Liverpool, GB)

Pulmonary hypertension is an adverse risk factor for peri-procedural complications in patients undergoing cardioversion for atrial fibrillation

Speaker: Doctor M. Kodali (Milwaukee, US)

Access the full session

Prognosis and outcome in patients with atrial fibrillation

Speakers: Doctor J. Choi, Mr R. Peter, Doctor R. Sandhu, Doctor G. Peigh, Doctor A. Fawzy...

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources